Clinical Trial Update: Efficacy and Safety of Fexinidazole in Children at Least 6 Years Old and Weighing Over 20 kg With Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open Study, plug-in to the Pivotal Study [Phase 2, Phase 3]

View source ↗

Summary

Prospective multicenter trial evaluating efficacy and safety of fexinidazole in children ≥6 years old and >20 kg with HAT due to T.b. gambiense; completed phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human African Trypanosomiasis

Drugs mentioned

• Fexinidazole (fexinidazole)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Human African Trypanosomiasis (HAT) | Phase 2, Phase 3 | Status: COMPLETED